Search results for "Xcellerex"
Article
Cell-Culture Advances Test Bioreactor Performance Models
Galliher, chief technical officer for upstream and founder of Xcellerex, a Cytiva business. “Successful modeling of bioreactors can reduce costs associated with engineering testing and engineering run…
Article
Scale-Up Model of a mAb Process from Microbioreactor to XDR-1000
A theoretical scale-up study was performed on a mAb process based on physical characterizations done on the Xcellerex XDR platform, from micro reactors up to large production-sized reactors. All inves…
Article
Achieving Process Balance with Perfusion Bioreactors
Liquid management is different for batch and perfusion processes, according to Yasser Kehail, Xcellerex global product manager at Cytiva. “For a perfusion process, you may need to add a vessel volume …
Article
Biopharma Says It Has an Evolution in New Technologies and Processes
Galliher, CTO, Upstream, Cytiva and founder of Xcellerex Inc., recommended that biopharma companies conduct a bottleneck analysis to see if continuous manufacturing may help in process segments.
A…
Article
Industry Adoption of Single-Use Systems Remains Low
One of the company’s most important investments was the 2012 acquisition of Xcellerex, a supplier of manufacturing technologies, including FlexFactory for biologics, a centrally automated, flexible bi…
Poster
Adenovirus production in a single-use stirring tank bioreactor system
By evaluating different cell culture media (CCM) and optimizing the virus propagation in small scale, the process could be successfully established in Xcellerex™ XDR-10 Bioreactor (10 L working volume…
Article
E. coli growth and Dab expression in single-use and stainless steel fermentors
This application note describes the performance of the Xcellerex™ single-use XDR-50 MO stirred-tank fermentor in an E. coli domain antibody (Dab) production process developed for a stainless steel …
Article
Trends in Single-use Bioreactors
…product manager, bioprocess at Eppendorf; Parrish Galliher, founder and chief technology officer at Xcellerex, Cytiva; and Mikel Sherman, global product manager of single-use bioreactors at Sartorius…
Article
Bioprocessing Advances in Vaccine Manufacture
Companies developing modular systems for vaccine manufacture include G-Con, which is working with partners, including Sartorius Stedim Biotech and GE/Xcellerex. For example, Project GreenVax, a privat…